Dr. Xiongbin Lu received a Ph.D. from Shanghai Institute of Biochemistry, Chinese Academy of Sciences in 1998 (Biochemistry). He did postdoctoral studies at NIAID/NIH (1998-2000) and at Baylor College of Medicine (2000-2003) and then joined the Faculty in Baylor College of Medicine as a Research Assistant Professor. In 2007, he was recruited as a Tenure-track investigator to the Center for Colon Cancer Research at the University of South Carolina. In 2010, he moved to the Department of Cancer Biology, University of Texas MD Anderson Cancer Center and was promoted to Associate Professor in 2012. In 2017, Dr. Lu moved to Indiana University School of Medicine and was named as Vera Bradley Foundation Professor of Breast Cancer Innovation and Strategic Research Initiative Distinguished Investigator.
Dr. Lu’s research interest spans across the field of cancer research, including human cancer genomics, targeted cancer therapy and cancer immunotherapy with a focus on solid tumors. He also has a long-standing interest in biomedical engineering. Dr. Lu was inducted to the College of Fellows at American Institute for Medical and Biological Engineering in 2019. Dr. Lu has made a number of seminal discoveries that promote translational development of human cancer research. Since independent, he has trained a number of postdoctoral fellows, graduate and undergraduate students in his laboratory. Three of his postdoctoral fellows were NIH K99/R00 awardees and seven of his past trainees are now independent investigators in the US and other nations.